Avital Eliasov (MBA’04J) was appointed Chief Executive Officer of Quantum Global Capital
Advisors in April 2012.
As reported in the previous newsletter, Michael Maeder (IEP’07Mar) assumed his new role
as CEO of STC Switzerland Travel Centre AG on 15 February.
In March, Andrea Orcel (MBA’90J) was appointed co-CEO of UBS Investment Bank alongside
Michel Orsinger (AMP’96Jun) was appointed to the board of Nobel Biocare. Michel has been the President and CEO of Synthes, Inc. since 2007.
The board of directors of Metall Zug AG appointed Christoph Schüpbach (AMP08Jul) to the Group’s executive management with effect from October 1. Christoph will retain his role as CEO of subsidiary, Schleuniger Holding AG.
François Simon (MBA’80) has joined the executive board of MainFirst Holding AG, holding company of the an independent, privately owned bank.